Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Outstanding (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Shares Outstanding for 3 consecutive years, with $51.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 157.44% to $51.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.9 million through Dec 2025, up 157.44% year-over-year, with the annual reading at $51.9 million for FY2025, 157.44% up from the prior year.
  • Shares Outstanding hit $51.9 million in Q4 2025 for Camp4 Therapeutics, up from $46.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $51.9 million in Q4 2025 to a low of $407741.0 in Q3 2023.
  • Historically, Shares Outstanding has averaged $16.2 million across 3 years, with a median of $10.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding: surged 146.71% in 2024 and later surged 4560.38% in 2025.
  • Year by year, Shares Outstanding stood at $460704.0 in 2023, then skyrocketed by 4276.14% to $20.2 million in 2024, then soared by 157.44% to $51.9 million in 2025.
  • Business Quant data shows Shares Outstanding for CAMP at $51.9 million in Q4 2025, $46.9 million in Q3 2025, and $20.2 million in Q2 2025.